Literature DB >> 2103758

Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation.

D A Johnston1, I N Marks, G O Young, N A Tigler-Wybrandi, S Bridger.   

Abstract

The effect of duodenal ulcer healing on the acid secretory responses to modified sham feeding and maximal pentagastrin stimulation has been studied in 17 patients treated successfully with ranitidine (n = 9) and sucralfate (n = 8). Parietal cell sensitivity was calculated as the ratio of the modified sham feeding response to the peak pentagastrin response, expressed as a percentage. Ulcer healing after sucralfate therapy resulted in significant falls in modified sham feeding stimulated acid output (P less than 0.02), from 9.4 (1.8-17.0) (median + range) to 3.7 (0.2-9.4) mmol/h; in peak acid output (P less than 0.05) from 42.8 (23.0-61.4) to 27.7 (7.2-51.0) mmol/h; and in the parietal cell sensitivity (P less than 0.05) from 19.2 (4.4-42.6) to 14.3 (2.8-19.7)%. No significant falls in any of these parameters were noted following ulcer healing with ranitidine. Duodenal ulcer healing with sucralfate results in decreased acid secretory responses to vagal and pentagastrin stimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103758     DOI: 10.1111/j.1365-2036.1990.tb00486.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

1.  Helicobacter pylori eradication, duodenal ulcer healing, and gastric secretory state.

Authors:  J A Louw; I N Marks
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

Review 2.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.

Authors:  A F Kummer; D A Johnston; I N Marks; G O Young; N A Tigler-Wybrandi; S A Bridger
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 4.  The H2-receptor antagonist era in duodenal ulcer disease.

Authors:  I N Marks
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.